A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
Year: 2022
Type: article
Source: Med
Authors: Ronald R. Cobb, Joseph Nkolola, Pavlo Gilchuk, Abishek Chandrashekar, Jingyou Yu, Robert V. House, Christopher G. Earnhart, Nicole M. Dorsey, Svetlana A. Hopkins, Doris M. Snow, Rita E. Chen, Laura A. VanBlargan, Manuel Hechenblaickner, Brian Hoppe, Laura Collins, Milan T. Tomic, Genevieve H. Nonet, Kyal Hackett, James C. Slaughter, Mark G. Lewis, Hanne Andersen, Anthony Cook, Michael S. Diamond, Robert H. Carnahan, Dan H. Barouch, James E. Crowe
Institutions: Beth Israel Deaconess Medical Center, Harvard University, Vanderbilt University Medical Center, United States Department of Defense, Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, Logistics Management Institute (United States), Washington University in St. Louis, Bioqual, Vanderbilt University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, AstraZeneca, Vanderbilt University, Takeda Pharmaceutical Company, Merck KGaA, Vir Biotechnology, National Institutes of Health, Defense Advanced Research Projects Agency, Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, National Cancer Institute, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W4210405015